Xijing Hospital: Cerebral Infarction trials
The registry lists 11 Cerebral Infarction studies with Xijing Hospital as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 5Phase 3 2Phase 4 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular DiseasesRecruitingNCT01372800
- Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)Active, not recruitingNCT05512910Phase 4
- Predictive Study of Serum Endocan for Hemorrhagic Transformation After Reperfusion Therapies in Acute Ischemic StrokeStatus unknownNCT05228080
- Low-dose Aspirin Therapy in Patients With Ischemic Stroke and MicrobleedsStatus unknownNCT04504864Phase 4
- Fatal Cerebral Infarction After Nasal Augmentation With Hyaluronic AcidCompletedNCT04189068
- Edoxaban for TIA and Acute Minor StrokeStatus unknownNCT02221102Phase 2/3
- Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral InfarctionStatus unknownNCT01851759Phase 2
- Mildronate for Acute Ischemic StrokeCompletedNCT01831011Phase 2
- Efficacy and Safety of Mildronate for Acute Ischemic StrokeStatus unknownNCT01800357Phase 2
- Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic StrokeCompletedNCT00815763Phase 3
- Ginsenoside-Rd for Acute Ischemic StrokeCompletedNCT00591084Phase 2